The British Heart Foundation (BHF) announced the winners of its annual ‘Reflections of Research’ image competition, reflecting the charity’s research into heart and circulatory disease.

Cancer patients often experience significant fluctuations in weight and lean body mass (LBM). Neglecting to account for these changes can prevent clinicians from obtaining precise data from molecular imaging, but a new method of measuring LBM takes changes in individual body composition into account for better staging of disease and therapy monitoring, said researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 11-15 in San Diego.

The Centers for Medicare & Medicaid Services (CMS) has named the American College of Radiology (ACR) a “qualified Provider-Led Entity” (qPLE) approved to provide appropriate use criteria (AUC) under the Medicare Appropriate Use Criteria program for advanced diagnostic imaging.

Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 11-15 in San Diego, an investigative blood test could predict how patients will respond to peptide receptor radionuclide therapy (PRRT) before they commit to a course of treatment.

The triggers of autoimmune inflammation in multiple sclerosis (MS) have eluded scientists for many years, but molecular imaging is bringing researchers closer to identifying them, according to a new study.

Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2017 Annual Meeting

Aggressive neuroendocrine cancer is something of a dark horse — a rare, elusive and persevering force linked to discouraging long-term survival rates. Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) — held June 11-15 in San Diego — presented a molecular imaging technique that allows oncologists to set patients’ radiotherapy doses right at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital organs.

Non-small cell lung cancers (NSCLC) have a collective reputation for not responding very well to chemotherapy. Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 11-15 in San Diego, presented a means of evaluating an immunotherapy that fights off NSCLC by strengthening a patient’s own immune system.

iCAD announced its support for the new U.S. Preventive Services Task Force (USPSTF) recommendations for colorectal cancer (CRC) screening that include use of computed tomography colonography (CTC).

Revolutions need data. They need to explain why the present is not working as well as it could, so that a better route might be mapped. But how to gather that information? Data mining may light the way.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now